Lv31
366 积分 2024-01-29 加入
Development of PROTAC Degrader Drugs for Cancer
2小时前
求助中
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1个月前
已完结
Structural Insights into Small-Molecule KRAS Inhibitors for Targeting KRAS Mutant Cancers
1个月前
已完结
Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies
2个月前
已完结
What influences the activity of Degrader−Antibody conjugates (DACs)
3个月前
已完结
A patent review of small molecule CDK4/6 inhibitors in the treatment of cancer: 2020—present
3个月前
已完结
Synthetic routes and clinical application of Small-Molecule HER2 inhibitors for cancer therapy
3个月前
已完结
Therapeutic targeting of the KIF18A motor protein in cancers with chromosomal instability
3个月前
已完结
Preparation of 3‐aminoalkylbenzo[b]thiophenes
4个月前
已完结
Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases
4个月前
已完结
皖公网安备34019202002308
